H2 Equity Partners takes majority stake in Lynch Medical Supplies

The private equity investment firm H2 Equity Partners has completed its acquisition of an equity stake in Lynch Medical Supplies to execute a strategic expansion plan across Irish healthcare channels. Finalized and formally announced on July 29, 2026, the primary buyout transaction structures a joint investment by the London-based investment partnership alongside founder John Lynch and Managing Director Robert Buckley, who both retain an equity interest in the ongoing business. The existing executive management team under Robert Buckley continues to oversee commercial logistics, hospital supply agreements, and technical distribution operations. This transaction represents the fourth platform investment completed in 2026 through the H2EP Fund VI vehicle, and marks the eighth founder-led platform transaction undertaken by H2 Equity Partners within the healthcare and medtech segments. The private equity firm previously established exposure to Irish medical wholesaling through the buyout of Cork-based distributor Healthcare 21, subsequently funding its bolt-on acquisition of medtech specialist Aquilant from United Drug. The transaction framework aims to capitalize on existing exclusive agency agreements held with international manufacturers of orthopaedic devices and surgical implants, expanding distribution capacity across public hospitals, private clinics, and retail pharmacies operating throughout the Republic of Ireland and Northern Ireland.